Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 9619 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $1,000,000 for 

Year 1 of funding to the Servicos 

Provinciais de Sau ́de de Inhambane 

(SPS Inhambane), Mozambique. The 

award will strengthen the institutional 

capacity of SPS Inhambane to plan, 

coordinate, and supervise HIV-related 

activities to contribute to accelerated 

progress towards the 95–95–95 goals 

(95% of HIV-positive individuals 

knowing their status, 95% of those 

receiving ART [Antiretroviral therapy], 

and 95% of those achieving viral 

suppression) and ensure sustainable 

control of the epidemic in Mozambique. 

Funding amounts for years 2–5 will be 

set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Meghan Duffy, Center for Global Health, 

Centers for Disease Control and 

Prevention, U.S. Embassy Maputo, 

Avenida Marginal nr 5467, 

Sommerschield, Distrito Municipal de 

KaMpfumo Caixa Postal 783 CEP 0101– 

11 Maputo, Moc ̧ambique, Telephone: 

800–232–6348, E-Mail: wwp2@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will focus on 

building institutional capacity of the 

SPS in Inhambane for program 

development and planning and 

strengthening program implementation 

and oversight of activities related to HIV 

prevention, care, support, and treatment 

services funded by PEPFAR in 

Mozambique. 

SPS Inhambane is in a unique 

position to conduct this work, as it is 

the sole organization tasked with 

ensuring the execution of health 

activities at the provincial level in 

Inhambane [Decree 26/2020]. In 

Mozambique, the governmental public 

health infrastructure is organized into 

the central or national entity of the 

Mozambique Ministry of Health/ 

Ministe ́rio da Sau ́de (MOH/MISAU), the 

Provincial Health Directorates (DPSs) 

that implement activities at the primary 

healthcare level, and the Provincial 

Health Service (SPS) that lead all health 

services within the province of 

Inhambane. The SPSs in Mozambique 

are government organizations 

established by law and mandated to 

plan, coordinate, and supervise all 

health-related activities at the tertiary 

and secondary level, including HIV/ 

AIDS activities, within their provincial 

jurisdiction. 

Summary of the Award 

Recipient: SPS Inhambane, 

Mozambique. 

Purpose of the Award: The purpose of 

this award is to strengthen the 

institutional capacity of SPS Inhambane 

to plan, coordinate, and supervise HIVrelated activities to contribute to 

accelerated progress towards the 95–95– 

95 goals and ensure sustainable control 

of the epidemic in Mozambique. 

Amount of Award: The approximate 

year 1 funding amount will be 

$1,000,000 in Federal Fiscal Year (FFY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 16, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–03723 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund Cote 

d’Ivoire Ministry of Health and Public 

Hygiene and Universal Health 

Coverage (MSHPCMU) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS) announces the 

award of approximately $3,000,000 for 

Year 1 of funding to the (MSHPCMU). 

The award will strengthen the capacities 

of the Ministry of Health (MOH) at the 

central and decentralized levels for HIV/ 

TB infection control interventions. 

Funding amounts for years 2–5 will be 

set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Titania Techeira, Center for Global 

Health, Centers for Disease Control and 

Prevention, CDC Coˆte d’Ivoire, U.S. 

Embassy B.P. 730 Abidjan Cidex 03, 

Telephone: 800–232–6348, E-Mail: 

iux2@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will (1) Provide 

technical, programmatic, financial, and 

administrative support to the ministry 

departments for the implementation, 

coordination, mobilization, and 

supervision of key central-level 

prevention, care, and treatment 

activities; (2) Link and coordinate 

specific activities of various health 

ministry departments at the central and 

decentralized levels with related 

activities by other ministries in the 

multi-sectoral HIV/AIDS response; (3) 

Develop a sustainability plan which 

places an emphasis on national 

commitment to health and HIV/AIDS 

effort; (4) Plan, monitor, evaluate, and 

coordinate expanded service delivery of 

prevention of mother to child 

transmission (PMTCT), counseling and 

testing (CT); and anti-retroviral therapy 

(ART) in collaboration with the national 

HIV and TB program. 

The MOH is the only eligible 

applicant that can apply for this funding 

opportunity because it is the sole public 

sector entity in Cote d’Ivoire mandated 

by the government to address the 

public’s health needs. This mandate 

includes: (1) Coordination, monitoring 

and evaluation of comprehensive STI/ 

TB and HIV prevention, and care and 

treatment services; (2) Coordination of 

HIV/AIDS interventions at decentralized 

levels of the health sector in Cote 

d’Ivoire; (3) Lead GoCI institution for 

strengthen the regulatory framework 

and promote hygiene to prevent 

diseases related to poor hospital 

hygiene; (4) Lead the GoCI in 

strengthening the SI management in the 

Ivorian national health sector response 

to HIV/AIDS; and Lead the GoCI for the 

development of the national M&E plan 

to monitor and evaluate the 

implementation of the activities and the 

results throughout the Ivoirian territory 

and at different levels of the health 

pyramid. 

Summary of the Award 

Recipient: MSHPCMU. 

Purpose of the Award: The purpose of 

this award is to strengthen the 

capacities of the MOH at the central and 

decentralized levels for HIV/TB 

infection control interventions to: (1) 

Improve the coordination of HIV/AIDS 

control interventions at the 

decentralized levels of the health sector; 

(2) Strengthen the regulatory framework 

and promote hygiene to prevent HIV 

infection and healthcare-related 

infections; and Strengthen the 

management of SI for the health sector 

national response. 


lotter on DSK11XQN23PROD with NOTICES1
9620 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 

Amount of Award: The approximate 

year 1 funding amount will be 

$3,000,000 in Federal Fiscal Year (FYY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: Public Law 108–25 (the 

United States Leadership Against HIV 

AIDS, Tuberculosis and Malaria Act of 

2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 15, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–03631 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–21HD] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled the ‘‘One Health 

Surveillance for Zoonotic SARS–CoV–2 

Events’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on August 

13, 2021 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

One Health Surveillance for Zoonotic 

SARS–CoV–2 Events—New—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

NCEZID seeks OMB approval for One 

Health Surveillance for Zoonotic SARS– 

CoV–2 Events through the use of two 

forms: One Health Case Investigation 

Form for Animals with SARS–CoV–2, 

and Zoonotic SARS–CoV–2 Event Form. 

Description of these forms and activities 

associated with this study, including 

burden to respondents can be found 

below. 

Zoonotic SARS–CoV–2 Event Form: 

Although it is now well established that 

SARS–CoV–2 is a zoonotic virus (i.e., 

can be spread between people and 

animals), little information exists on the 

prevalence or likelihood of zoonotic 

transmission events. Currently, 

reporting of zoonotic SARS–CoV–2 

transmission events is not 

systematically reported. Without this 

crucial information, however, 

interpreting data on SARS–CoV–2 

infection in animals, especially the 

overall contribution of zoonotic 

transmission to the spread of COVID– 

19, is incomplete. The information 

gathered using this surveillance 

mechanism will provide insight into the 

role of animals in SARS–CoV–2 

transmission and will also provide 

context for understanding prevalence of 

linked human and animal infections 

throughout the nation. 

Positive SARS–CoV–2 animal samples 

must be confirmed by United States 

Department of Agriculture (USDA) 

National Veterinary Services Lab 

(NVSL); however, without the proposed 

surveillance mechanism, data on linked 

human and animal transmission events 

which yield negative results would not 

be tracked at the national level. CDC 

and USDA guidance recommends statelevel health authorities, namely state 

public health veterinarians and state 

animal health officials, are involved in 

approving and coordinating animal 

SARS–CoV–2 testing. These officials are 

therefore the primary target audience for 

this surveillance form, in addition to 

tribal, local and territorial health 

authorities. The Zoonotic SARS–CoV–2 

Event form includes questions intended 

to improve our understanding of the 

number of cases state officials are asked 

to consult upon regarding SARS–CoV– 

2 testing for potential zoonotic 

transmission events, the proportion of 

those events that are tested for SARS– 

CoV–2, and corresponding relevant 

epidemiological data (epidemiological 

links to other cases of SARS–CoV–2 in 

people or animals, clinical signs, etc.), 

results, etc. This form will fill a needed 

gap over the next three years. 

In addition to the primary reason for 

the Zooonotic SARS–CoV–2 Event form, 

it will also be used to replace paperbased reporting for CDC-funded 

research. Currently, CDC’s One Health 

Office has funded surveillance and 

research at sites throughout the nation. 

This surveillance form will be used to 

report all linked human and animal 

testing for SARS–CoV–2 to CDC that is 

occurring through funded surveillance 

activities, including the status and 

circumstances for testing. This will 

relieve the requirement for less secure 

reporting such as paper-based reporting 

forms sent through email. 

More broadly, we expect this form 

may be generalized in the future to 

encapsulate surveillance for other 

zoonotic respiratory viruses. This 

surveillance form therefore offers the 

opportunity to test and iterate upon 

surveillance mechanisms prior to the 

advancement of a broader surveillance 

system. 

One Health Case Investigation Form 

for Animals with SARS–CoV–2: 

Currently, most animal samples that test 

positive for SARS–CoV–2 are confirmed 

by USDA NVSL, and are reported to the 

World Organization for Animal Health 

(OIE). However, the information 

collected is largely restricted to 


lotter on DSK11XQN23PROD with NOTICES1